Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Inventory (2023 - 2025)

Tonix Pharmaceuticals Holding has reported Inventory over the past 3 years, most recently at $1.0 million for Q4 2025.

  • Quarterly results put Inventory at $1.0 million for Q4 2025, down 88.11% from a year ago — trailing twelve months through Dec 2025 was $1.0 million (down 88.11% YoY), and the annual figure for FY2025 was $1.0 million, down 88.11%.
  • Inventory for Q4 2025 was $1.0 million at Tonix Pharmaceuticals Holding, down from $5.7 million in the prior quarter.
  • Over the last five years, Inventory for TNXP hit a ceiling of $13.7 million in Q2 2023 and a floor of $508000.0 in Q4 2023.
  • Median Inventory over the past 3 years was $8.1 million (2025), compared with a mean of $7.9 million.
  • Biggest five-year swings in Inventory: soared 1555.12% in 2024 and later tumbled 88.11% in 2025.
  • Tonix Pharmaceuticals Holding's Inventory stood at $508000.0 in 2023, then soared by 1555.12% to $8.4 million in 2024, then tumbled by 88.11% to $1.0 million in 2025.
  • The last three reported values for Inventory were $1.0 million (Q4 2025), $5.7 million (Q3 2025), and $6.0 million (Q2 2025) per Business Quant data.